BOK Financial Private Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Sell |
4,690
-2,810
| -37% | -$194K | 0.02% | 145 |
|
|
2025
Q1 | $529K | Sell |
7,500
-4,547
| -38% | -$321K | 0.04% | 121 |
|
|
2024
Q4 | $1.04M | Buy |
12,047
+32
| +0.3% | +$2.75K | 0.08% | 96 |
|
|
2024
Q3 | $1.43M | Buy |
12,015
+2,015
| +20% | +$240K | 0.1% | 87 |
|
|
2024
Q2 | $1.43M | Hold |
10,000
| – | – | 0.1% | 89 |
|
|
2024
Q1 | $1.29M | Hold |
10,000
| – | – | 0.1% | 91 |
|
|
2023
Q4 | $1.03M | Hold |
10,000
| – | – | 0.08% | 94 |
|
|
2023
Q3 | $909K | Hold |
10,000
| – | – | 0.08% | 95 |
|
|
2023
Q2 | $809K | Sell |
10,000
-54
| -0.5% | -$4.37K | 0.07% | 105 |
|
|
2023
Q1 | $806K | Buy |
10,054
+54
| +0.5% | +$4.33K | 0.06% | 109 |
|
|
2022
Q4 | $677K | Sell |
10,000
-5,000
| -33% | -$338K | 0.06% | 115 |
|
|
2022
Q3 | $747K | Hold |
15,000
| – | – | 0.07% | 112 |
|
|
2022
Q2 | $836K | Sell |
15,000
-5,280
| -26% | -$294K | 0.07% | 113 |
|
|
2022
Q1 | $1.13M | Buy |
20,280
+238
| +1% | +$13.2K | 0.08% | 127 |
|
|
2021
Q4 | $1.12M | Buy |
20,042
+10,312
| +106% | +$577K | 0.08% | 126 |
|
|
2021
Q3 | $467K | Buy |
9,730
+68
| +0.7% | +$3.26K | 0.04% | 152 |
|
|
2021
Q2 | $405K | Sell |
9,662
-12
| -0.1% | -$503 | 0.03% | 150 |
|
|
2021
Q1 | $326K | Buy |
9,674
+426
| +5% | +$14.4K | 0.03% | 151 |
|
|
2020
Q4 | $323K | Buy |
9,248
+798
| +9% | +$27.9K | 0.03% | 147 |
|
|
2020
Q3 | $293K | Buy |
8,450
+484
| +6% | +$16.8K | 0.03% | 141 |
|
|
2020
Q2 | $261K | Sell |
7,966
-304
| -4% | -$9.96K | 0.03% | 146 |
|
|
2020
Q1 | $249K | Sell |
8,270
-1,172
| -12% | -$35.3K | 0.03% | 155 |
|
|
2019
Q4 | $273K | Buy |
+9,442
| New | +$273K | 0.02% | 163 |
|